Amazon cover image
      Image from Amazon.com
      Image from Google Jackets

      Drug Treatment of Sleep Disorders [electronic resource] / edited by Antonio Guglietta.

      Contributor(s): Material type: TextTextSeries: Milestones in Drug TherapyPublisher: Cham : Springer International Publishing : Imprint: Springer, 2015Description: VIII, 297 p. 23 illus., 14 illus. in color. online resourceContent type:
      • text
      Media type:
      • computer
      Carrier type:
      • online resource
      ISBN:
      • 9783319115146
      Subject(s): Additional physical formats: Printed edition:: No titleDDC classification:
      • 615 23
      LOC classification:
      • RM1-950
      Online resources:
      Contents:
      An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem®): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.
      In: Springer eBooksSummary: Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.
      Tags from this library: No tags from this library for this title. Log in to add tags.
      Star ratings
          Average rating: 0.0 (0 votes)
      Holdings
      Item type Current library Call number URL Status Notes Date due Barcode
      e-Books e-Books SARVAJNA LIBRARY, UHS, BAGALKOT 615 (Browse shelf(Opens below)) Link to resource Available Click on the URL to access eBook EB132

      An overview of sleep physiology and sleep regulation -- Neuronal networks regulating sleep and arousal: effect of drugs -- Classification of sleep disorders -- Development of new therapeutical agents for treatment of insomnia and other sleep disorders -- Low dose doxepin for insomnia -- Lorediplon: a new GABAa modulator drug for treatment of insomnia -- Zolpidem sublingual formulations -- Eszopiclone: review and clinical applications in chronic and co-morbid insomnia -- Orexin/hypocretin antagonists in insomnia: from bench to clinic -- Modafinil and armodafinil -- Sodium oxybate (Xyrem®): a new and effective treatment for narcolepsy with cataplexy -- Cell therapy to treat narcolepsy -- Tasimelteon -- The past, present and future of drug development and treatment in sleep disorders.

      Following reviews on sleep physiology, regulation, pharmacology, and the neuronal networks regulating sleep and awakening, as well as a classification of sleep disorders, this book presents a number of major breakthroughs in the treatment of those disorders. These include recently approved drugs for treating insomnia, such as Doxepin; variations on previously approved molecules, e.g. Zolpidem sublingual preparation; or new chemical entities in advanced stages of clinical development, e.g. Orexin antagonists. Further topics discussed include drugs acting on the GABA receptor, such as Lorediplon and Eszopiclone; the treatment of excessive daytime drowsiness with cell therapy and drugs such as Modafinil, Armodafinil and Sodium oxybate; and the use of Tasimelteon in the treatment of circadian sleep disorders.

      There are no comments on this title.

      to post a comment.
      External Imp. Links

      UHSB || ICAR || IDEAL: A Union Catalog of NARS Libraries || KrushiKosh (Digital Library) || Kanaja (ಕಣಜ – ಕನ್ನಡ ಜ್ಞಾನಕೋಶ) || Karnataka Gazetteer || ASRB || Employment News || ಉದ್ಯೋಗ ಮಾಹಿತಿ || || Karnataka Digital Public Library ||


      For more Information please contact Librarian @ Sarvajna Library, UHS, Bagalkot OR Dr. Gireesh A Ganjihal Assistant Librarian
      "Healthy Soils for a Healthy Life"

      page counter